CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) shares in Thousands, $ in Millions	Total	Common Stock And Surplus	Retained Earnings (Deficit)	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at May. 30, 2021		130,800
Beginning balance at May. 30, 2021	$ 2,813.1	$ 2,286.6	$ 522.3	$ 4.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	671.1		671.1
Other comprehensive income (loss)	(2.2)			(2.2)
Dividends declared	(427.9)		(427.9)
Stock option exercises (in shares)		500
Stock option exercises	28.7	$ 28.7
Stock-based compensation	28.0	$ 28.0
Repurchases of common stock (in shares)		(5,800)
Repurchases of common stock	(834.1)	$ (102.6)	(731.5)
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)		200
Issuance of stock under Employee Stock Purchase Plan and other plans	7.7	$ 7.7
Other	1.4	$ 1.4
Ending balance (in shares) at Feb. 27, 2022		125,700
Ending balance at Feb. 27, 2022	2,285.8	$ 2,249.8	34.0	2.0
Beginning balance (in shares) at Nov. 28, 2021		128,300
Beginning balance at Nov. 28, 2021	2,543.0	$ 2,280.6	261.8	0.6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	247.0		247.0
Other comprehensive income (loss)	1.4			1.4
Dividends declared	(140.7)		(140.7)
Stock option exercises (in shares)		100
Stock option exercises	8.1	$ 8.1
Stock-based compensation	6.1	$ 6.1
Repurchases of common stock (in shares)		(2,700)
Repurchases of common stock	(381.8)	$ (47.7)	(334.1)
Issuance of stock under Employee Stock Purchase Plan and other plans	2.6	2.6
Other	0.1	$ 0.1
Ending balance (in shares) at Feb. 27, 2022		125,700
Ending balance at Feb. 27, 2022	2,285.8	$ 2,249.8	34.0	2.0
Beginning balance (in shares) at May. 29, 2022		123,900
Beginning balance at May. 29, 2022	2,198.2	$ 2,226.0	(25.9)	(1.9)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	666.8		666.8
Other comprehensive income (loss)	2.0			2.0
Dividends declared	$ (446.7)		(446.7)
Stock option exercises (in shares)	190	200
Stock option exercises	$ 10.0	$ 10.0
Stock-based compensation	27.8	$ 27.8
Repurchases of common stock (in shares)		(3,300)
Repurchases of common stock	(423.5)	$ (59.9)	(363.6)
Issuance of stock under Employee Stock Purchase Plan and other plans (in shares)		300
Issuance of stock under Employee Stock Purchase Plan and other plans	8.3	$ 8.3
Other	1.0	$ 1.0
Ending balance (in shares) at Feb. 26, 2023		121,100
Ending balance at Feb. 26, 2023	2,043.9	$ 2,213.2	(169.4)	0.1
Beginning balance (in shares) at Nov. 27, 2022		121,900
Beginning balance at Nov. 27, 2022	2,020.9	$ 2,214.6	(199.7)	6.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	286.6		286.6
Other comprehensive income (loss)	(5.9)			(5.9)
Dividends declared	(147.8)		(147.8)
Stock option exercises (in shares)		100
Stock option exercises	3.8	$ 3.8
Stock-based compensation	7.9	$ 7.9
Repurchases of common stock (in shares)		(900)
Repurchases of common stock	(124.3)	$ (15.8)	(108.5)
Issuance of stock under Employee Stock Purchase Plan and other plans	2.8	2.8
Other	(0.1)	$ (0.1)
Ending balance (in shares) at Feb. 26, 2023		121,100
Ending balance at Feb. 26, 2023	$ 2,043.9	$ 2,213.2	$ (169.4)	$ 0.1